BNP Paribas Financial Markets’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,535
| Closed | -$14.1K | – | 3461 |
|
|
2021
Q2 | $14.1K | Sell |
1,535
-3,638
| -70% | -$33.4K | ﹤0.01% | 3038 |
|
|
2021
Q1 | $25.7K | Sell |
5,173
-2,774
| -35% | -$13.8K | ﹤0.01% | 3151 |
|
|
2020
Q4 | $34.3K | Sell |
7,947
-1,461
| -16% | -$6.3K | ﹤0.01% | 3053 |
|
|
2020
Q3 | $40.4K | Buy |
9,408
+7,369
| +361% | +$31.6K | ﹤0.01% | 2949 |
|
|
2020
Q2 | $9.16K | Sell |
2,039
-9,365
| -82% | -$42K | ﹤0.01% | 3126 |
|
|
2020
Q1 | $45.6K | Buy |
11,404
+6,306
| +124% | +$25.2K | ﹤0.01% | 2972 |
|
|
2019
Q4 | $43.2K | Sell |
5,098
-724
| -12% | -$6.14K | ﹤0.01% | 3056 |
|
|
2019
Q3 | $39.9K | Buy |
5,822
+1,683
| +41% | +$11.5K | ﹤0.01% | 2971 |
|
|
2019
Q2 | $34.5K | Sell |
4,139
-3,379
| -45% | -$28.1K | ﹤0.01% | 3028 |
|
|
2019
Q1 | $68.9K | Buy |
7,518
+7,509
| +83,433% | +$68.9K | ﹤0.01% | 2750 |
|
|
2018
Q4 | $99 | Sell |
9
-1,318
| -99% | -$14.5K | ﹤0.01% | 3503 |
|
|
2018
Q3 | $18.5K | Buy |
1,327
+384
| +41% | +$5.36K | ﹤0.01% | 2775 |
|
|
2018
Q2 | $10K | Sell |
943
-5,364
| -85% | -$57.1K | ﹤0.01% | 3131 |
|
|
2018
Q1 | $54.6K | Sell |
6,307
-1,077
| -15% | -$9.32K | ﹤0.01% | 2940 |
|
|
2017
Q4 | $69.8K | Buy |
7,384
+3,677
| +99% | +$34.7K | ﹤0.01% | 2830 |
|
|
2017
Q3 | $29.1K | Buy |
3,707
+1,500
| +68% | +$11.8K | ﹤0.01% | 2917 |
|
|
2017
Q2 | $19K | Buy |
+2,207
| New | +$19K | ﹤0.01% | 3148 |
|
|
2015
Q2 | – | Sell |
-247
| Closed | -$1.76K | – | 3660 |
|
|
2015
Q1 | $1.76K | Buy |
+247
| New | +$1.76K | ﹤0.01% | 3490 |
|
|
2014
Q4 | – | Sell |
-700
| Closed | -$6.48K | – | 3021 |
|
|
2014
Q3 | $6.48K | Buy |
700
+588
| +525% | +$5.44K | ﹤0.01% | 3244 |
|
|
2014
Q2 | $2.09K | Buy |
+112
| New | +$2.09K | ﹤0.01% | 2601 |
|